Carnegie Corporation and the UC Institute on Global Conflict and Cooperation. He is a member of the American Society for Clinical Investigation and the Association of American Physicians. Dr. Bozzette holds an M.D. from the University of Rochester and a Ph.D. in Policy Analysis with Distinction in Economics and Quantitative Methods from the Pardee RAND Graduate School of Policy Studies. He has participated in many national, institutional, and civic committees, including an IOM committee on reviewing data needs for the Ryan White Care Act, the VA’s National Committee on Clinical Practices Guidelines, and advisory boards for the Zoological Society of San Diego.
David D. Celentano, Sc.D., M.H.S., is a Professor and Director of the Infectious Disease and Epidemiology program and Deputy Chair of the Department of Epidemiology, with joint appointments in the School of Medicine, and International Health and Health, Behavior and Society at the Johns Hopkins University Bloomberg School of Public Health. His research integrates behavioral science theory and research with epidemiology, in the study of infectious diseases. While trained in a chronic disease paradigm (alcoholism and cancer control), he began his research in HIV/AIDS and sexually transmitted diseases (STDs) in the early 1980s. He has worked on some of the major cohort studies (ALIVE, MACS) in HIV epidemiology, as well as conducted intervention research in the United States for heterosexual men and women, injection drug users, and young men who have sex with men. He returned to international research in 1990, when he began a long-term collaboration with Chiang Mai University in northern Thailand. He has worked on and directed numerous HIV/AIDS and STD epidemiological investigations and preventive interventions. More recently, his group has been conducting a prospective study of hormonal contraception in relation to HIV seroconversion, a study with significant family planning policy and health implications. He is currently the Principal Investigator of four NIH-supported studies in Thailand and one in India, focusing on interventions to influence the association between opiate use, methamphetamine use, and other drugs on HIV as well as community-randomized HIV prevention trials. The focus of these interventions is to harness indigenous peer networks for risk reduction. He has over 300 peer-reviewed publications and numerous book chapters. Dr. Celentano has served on two previous IOM studies including the committee reviewing data needs for the Ryan White Care Act and the committee on prevention and control of sexually transmitted diseases.
Mathea Falco, J.D., is the President of Drug Strategies, a nonprofit research institute in Washington, D.C., that identifies more effective approaches to substance abuse. She is also Associate Professor of Public Health at the